ESC 2021: Finerenone Reduces Cardiovascular Risk in Patients With Diabetes and A Wide Range of Kidney Disease Severities
Benefits may also extend to renal protection
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.